Patent Assignment
Reel/Frame 030710/0299
Assignment of Assignor's Interest
Recorded: 2013-06-25
Pages: 14
Assignors
DUNAYEVICH, EDUARDO
Executed: 2011-12-24
MCELROY, SUSAN
Executed: 2012-01-12
LANDBLOOM, RON
Executed: 2012-01-15
Assignee
OREXIGEN THERAPEUTICS, INC.
SUITE 200, 3344 NORTH TORREY PINES COURT, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Methods for Reducing Binge or Compulsive Eating
Application:
13/991,372 →
Publication:
US 2013/0252995
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Assignment of Assignor's Interest
Oct 24, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 047960/0001 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →